Synthesis and Biological Evaluation of Geminal Disulfones as HIV-1 Integrase Inhibitors
Authors:
- 14 June 2005
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 48 (14) , 4526-4534
Abstract
Integration of HIV-1 viral DNA into the host genome is carried out by HIV-integrase (IN) and is a critical step in viral replication. Although several classes of compounds have been reported to inhibit IN in enzymatic assays, inhibition is not always correlated with antiviral activity. Moreover, potent antiviral IN inhibitors such as the chicoric acids do not act upon the intended enzymatic target but behave as entry inhibitors instead. The charged nature of the chicoric acids contributes to poor cellular uptake, and these compounds are further plagued by rapid ester hydrolysis in vivo. To address these critical deficiencies, we designed neutral, nonhydrolyzable analogues of the chicoric acids. Herein, we report the synthesis, enzyme inhibition studies, and cellular antiviral data for a series of geminal disulfones. Of the 10 compounds evaluated, 8 showed moderate to high inhibition of IN in purified enzyme assays. The purified enzyme data correlated with antiviral assays for all but two compounds, suggesting alternative modes of inhibition. Time-of-addition studies were performed on these analogues, and the results indicate that they inhibit an early stage in the replication process, perhaps entry. In contrast, the most potent member of the correlative group shows behavior consistent with IN being the cellular target.Keywords
This publication has 21 references indexed in Scilit:
- Efavirenz Therapy in Rhesus Macaques Infected with a Chimera of Simian Immunodeficiency Virus Containing Reverse Transcriptase from Human Immunodeficiency Virus Type 1Antimicrobial Agents and Chemotherapy, 2004
- Integrase Inhibitors and Cellular Immunity Suppress Retroviral Replication in Rhesus MacaquesScience, 2004
- Susceptibilities of Simian Immunodeficiency Virus to Protease InhibitorsAntimicrobial Agents and Chemotherapy, 2003
- Reversion of the M184V Mutation in Simian Immunodeficiency Virus Reverse Transcriptase Is Selected by Tenofovir, Even in the Presence of LamivudineJournal of Virology, 2003
- Inhibition of Human Immunodeficiency Virus Type 1 Integration by Diketo DerivativesAntimicrobial Agents and Chemotherapy, 2002
- Patented small molecule inhibitors of HIV-1 integrase: a 10-year sagaExpert Opinion on Therapeutic Patents, 2002
- Real-Time TaqMan PCR as a Specific and More Sensitive Alternative to the Branched-Chain DNA Assay for Quantitation of Simian Immunodeficiency Virus RNAAIDS Research and Human Retroviruses, 2001
- A New Class of HIV-1 Integrase Inhibitors: The 3,3,3‘,3‘-Tetramethyl-1,1‘-spirobi(indan)-5,5‘,6,6‘-tetrol FamilyJournal of Medicinal Chemistry, 2000
- The AIDS Epidemic — Considerations for the 21st CenturyNew England Journal of Medicine, 1999
- Preparation and ring-opening of benzylic and allylic cyclopropyl dianionsThe Journal of Organic Chemistry, 1992